Epiminder Limited (ASX:EPI)
Australia · Delayed Price · Currency is AUD 0.3500
-0.0150 (-4.11%)
At close: Aug 28, 2026
Epiminder Market Cap
Epiminder has a market cap or net worth of 78.97 million as of August 28, 2026.
Market Cap
78.97M
Enterprise Value
62.83M
Revenue
2.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
ChartMarket Cap Chart
Since December 1, 2025, Epiminder's market cap has decreased from 283.42M to 78.97M, a decrease of -72.14%. That is a compound annual growth rate of -82.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 78.97M | -64.22% |
| Dec 31, 2025 | 220.68M | -22.14% |
| Dec 1, 2025 | 283.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aroa Biosurgery | 193.71M |
| EMVision Medical Devices | 160.35M |
| Saluda Medical | 156.25M |
| Lumos Diagnostics Holdings | 94.44M |
| SomnoMed | 72.30M |
| Cyclopharm | 64.12M |
| Compumedics | 50.94M |
| Cleo Diagnostics | 49.36M |